biocept lung cancer detection

ESMO17 En İyiler

ESMO17 131 ülkeden 24.000'den fazla katılımcı ile son gününe geldi. Kongrede tartışılan 1.736 araştırma New England Journal of Medicine (NEJM), Lancet Oncology ve Annals of Oncology'de eş zamanlı olarak yayınlandı. Bu araştırmalar arasından uygulama değiştirici kabul edilerek seçilen en iyiler:

PACIFIC: New Standard of Care for Locally Advanced, Unresectable Stage III NSCLC

IFCT-0302: Questionned Regular Computed Tomography (CT) Scans in Resected NSCLC.

COMBI-AD: New Adjuvant Treatment Option for High-risk Melanoma.

CheckMate 238: Improved Adjuvant Therapy for Patients with Surgically Resected Stage III/IV Melanoma at High Risk of Relapse.

LORELEI: Greater Tumour Shrinkage in Estrogen Receptor ositive and  HER2 negative Early Breast Cancer.

MONARCH 3: Improved Outcomes with a New Initial Strategy for Postmenopausal Women with HR positive, HER2 negative Advanced Breast Cancer.

ARIEL 3: New Maintenance Therapy for Recurrent Ovarian Cancer.

RANGE: Promising Treatment for Advanced or Metastatic Urothelial Cancer.

CheckMate 214: Combination Therapy Reduces Kidney Cancer Death Risk